GENZYME CORP: In Dispute with Abbott on Portion of Liability
Genzyme Corp. is in a dispute with Abbott Laboratories over the percentage of infringing product that was supplied by the Company.
The Company said that it may in the future…
Genzyme Corp. is in a dispute with Abbott Laboratories over the percentage of infringing product that was supplied by the Company.
The Company said that it may in the future…
Becton Dickinson and Co. is facing Retractable Technologies Inc.’s suit in the U.S. District Court for the Eastern District of Texas, alleging that the Company’s Integra TM syringes infringe a…
Hologic Inc., on April 23, 2008, entered into a settlement agreement with Oleg Sokolov, under which the Company paid Sokolov a nominal sum and the parties dismissed all claims against…
Tissue Extraction Devices, LLC’s patent infringement complaint against Hologic Inc. in the U.S. District Court for the Southern District of Indiana is in the early stage of litigation.
On Jan. 9,…
The U.S. District Court for the Eastern District of Texas has scheduled to commence trial on Retractable Technologies Inc.’s patent claims against Becton Dickinson & Co. in March 2009.
RTI filed…
The amended patent infringement suit filed by Ethicon Endo-Surgery Inc. against Hologic Inc. and its subsidiary, Suros Surgical Systems Inc., in the U.S. District Court for the District of Ohio…
Hologic Inc.’s suit against SenoRx Inc. for the alleged infringement of U.S. Patent Nos. 5,913,813, 6,413,204, and 6,482,142 remains pending in the U.S. District Court for the Northern District of…
The U.S. District Court for the Southern District of New York has yet to set a trial date for Shire Ltd.’s suit against Teva Pharmaceuticals Industries Ltd. for the alleged…
Wyeth and its licensing partner, Nycomed GmbH, are pursuing a lawsuit against Sandoz Inc. in the U.S. District Court for the Northern District of Illinois, alleging infringement of U.S. Patent…
Wyeth pursues a lawsuit against Sandoz Inc. in the U.S. District Court for the District of Delaware, alleging that Sandoz’s filing of Abbreviated New Drug Application with the U.S. Food…